trending Market Intelligence /marketintelligence/en/news-insights/trending/lysahrmyaovya17xgcvcra2 content esgSubNav
In This List

Cancer Genetics chief medical officer leaves to pursue other research interests

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Cancer Genetics chief medical officer leaves to pursue other research interests

Cancer Genetics Inc. said Rita Shaknovich will resign as chief medical officer and group medical director effective Sept. 12.

The Rutherford, N.J.-based company believes its existing staff will be able to manage ongoing operations and is exploring internal promotions to ensure a smooth transition of Shaknovich's responsibilities.

Shaknovich plans to pursue other interests related to oncology research, the company said in an Aug. 10 regulatory filing.